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Background
Increased inflammation has been linked to myocardial
dysfunction and heart failure. We investigated whether
T1 mapping by cardiovascular magnetic resonance
(CMR) in patients with systemic lupus erythematosus
(SLE) can detect subclinical cardiac involvement.
Methods
A total of 37 SLE female patients subjects (mean age 41
±11years) underwent CMR for routine assessment of
cardiac perfusion, function and scar. T1 mapping was
performed in single short axis slice before and 15 min-
utes after gadolinium administration.
Results
Sixteen age-matched subjects from the clinical pool with a
low pre-test probability and normal CMR acted as a con-
trol group. Both groups had normal volumes and global
systolic function (ejection fraction (%): control vs. SLE
group: 60±13 vs. 56±12, p=0.57) and similar LV mass
index (LVmass index (g/ m2): 43±12 vs. 51±12 g/ m2,
p=0.18). SLE patients had significantly reduced longitudi-
nal strain (%, -19±4 vs. -16±3, p=0.05) and showed intra-
myocardial (70%) or pericardial (63%) late gadolinium
enhancement. SLE patients had significantly increased pre-
constrast myocardial T1 (T1native ) values and lambda
(p<0.01). In comparison of significant measures, we identi-
fied T1native as the strongest discriminator between the
patients and controls.
Conclusions
We demonstrate that in SLE patients without significant
coronary artery disease there is evidence of subclinical
perimyocardial involvement. Among variables to discern
the subclinical cardiomyopathic process, T1 mapping
performs best to discriminate between health and
disease.
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